Nexera XR Tried and trusted all-rounder
A true multi-talent, the Nexera XR ultra high performance liquid chromatograph has become an indispensable tool in laboratories of versatile industries, such as pharmaceuticals, biochemistry, chemistry, environmental and foods. Users benefit from high-speed, high-resolution analysis without compromising robustness or reliability.
The Nexera XR modular UHPLC system bridges the gap between the flexibility clients need and the reliability they want. The wide range of highly accurate and reliable modules provides the optimum system for analytical challenges in any field.
On the safe side – with a pressure resistance of 660 bar, the Nexera XR is a reliable all-round system, providing the superior performance of UHPLC with the robustness of a conventional HPLC system.
The flexible choice – modular design allows configuration of tailor-made systems to meet specific application requirements. Each module delivers outstanding, reliable performance from HPLC to UHPLC application.
The sensible option – the SPD-30AM multi-wavelength detector and RF-20Axs fluorescence detector offer unmatched performance. Equipped with unequalled optics and temperature control, these detectors achieve excellent sensitivity, baseline stability and reproducibility.
For more information please visit www.shimadzu.eu
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Your Ultimate Guide for CMC Testing Support for Gene and Cell Therapy
November 21st 2024Explore the complexities of gene and cell therapy development with our comprehensive guide to Chemistry, Manufacturing, and Controls (CMC) testing. Learn how our expertise ensures the safety, potency, and quality of advanced therapies, supporting your journey from product development through regulatory approval.
